Dr. Hans Herfarth discusses biosimilars, the differences of biosimilars and biologics and safety issues with switching from an original drug to a bios...
Dr. Jonathan Serody discusses immunotherapy as a way to treat cancer, specifically adoptive cell therapy, checkpoint inhibitor therapy and stem cell t...
Dr. John Buse shares what is new in the treatment of diabetes, and highlights the benefits that SGLT2 inhibitors and GLP-1 receptor agonists can offer...
Galafold (migalastat) was approved in August 2018 for the treatment of Fabry disease. Jerry Walter, a patient who has Fabry, and his nephrologist, Dr....
What is hemophilia? Dr. Nigel Key discusses this genetic disease with Dr. Ron Falk. They talk about how the disease is inherited, the effectiveness of...
Dr. Manish Saha talks with Dr. Ron Falk about thrombotic microangiopathy, or TMA. They discuss two types of TMA, thrombotic thrombocytopenic purpura a...
What is hereditary hemochromatosis? Dr. Sid Barritt discusses this disease with Dr. Ron Falk. This genetic condition causes excess iron to deposit in ...
Dr. Raj Kasthuri talks about hereditary hemorrhagic telangiectasia, also known as HHT, with Dr. Ron Falk. Dr. Kasthuri describes the symptoms, how it ...